In recent years, the insidious impact of prenatal exposure to various lifestyle-related and environmental chemicals on birth outcomes has garnered significant attention within the scientific community. Increasing evidence points towards the complex interplay between maternal exposures and genetic predispositions, suggesting that the genetic makeup of both mother and child can substantially modulate the risks associated with toxic chemical environments during pregnancy. A narrative review published in Pediatric Research in 2026 by Kobayashi and colleagues advances our understanding of these multifaceted gene-environment interactions, particularly excluding the well-studied effects of active and passive smoking. This expanded focus highlights the crucial need to disentangle genetic susceptibilities and chemical exposures to elucidate pathways that influence fetal growth and development.
One of the fundamental challenges in this field is the vast heterogeneity in both genetic polymorphisms and the spectrum of chemical exposures a pregnant woman may encounter. Historically, investigations have concentrated on polymorphisms within the cytochrome P450 (CYP) family, enzymes critical in the metabolism of countless xenobiotics. These enzymes can either detoxify or activate procarcinogens and other harmful substances, meaning natural variations in CYP genes might markedly alter an individual’s response to environmental chemicals. Similarly, members of the glutathione S-transferase (GST) family, which participate in cellular defense mechanisms by conjugating toxic electrophiles to glutathione, have been scrutinized for their polymorphic influence on detoxification efficacy. However, the recent narrative review underscores that gene-environment research is moving beyond these traditional candidates to embrace polymorphisms in genes associated with receptors, transporters, and signal transduction pathways in both mother and fetus.
This broad genomic consideration is crucial given the systemic complexity of chemical exposures during pregnancy. Environmental chemicals encompass a diverse array of substances—ranging from persistent organic pollutants, heavy metals, endocrine disruptors, to ubiquitous plasticizers and air pollutants. Each of these chemicals can interfere with intricate biological processes that regulate fetal growth, yet their effects can manifest differently depending on an individual’s unique genetic blueprint. Receptors, such as the aryl hydrocarbon receptor (AhR), play key roles in mediating the toxicity of many environmental chemicals. Polymorphisms affecting receptor function and expression could potentially modify the susceptibility of pregnant women and their fetuses to chemical insults. Likewise, transporter proteins that regulate the placental passage of substances further compound this biological complexity, highlighting the necessity for multifactorial genetic examination.
The review illuminated an essential yet challenging truth: the results regarding gene-environment interactions related to prenatal chemical exposures remain inconsistent across studies. These discrepancies can be attributed to numerous factors, including differences in cohort characteristics, chemical exposure assessment methodologies, genetic background diversity, and the timing and measurement of birth outcomes. Despite these challenges, a compelling consensus emerges from the collective data, indicating that prenatal chemical exposures are seldom innocuous and that genetic polymorphisms can either exacerbate or mitigate their adverse effects on fetal development.
Notably, prospective birth cohort studies dominate this research landscape, providing a valuable temporal framework to explore the causality underlying gene-environment interplay. These cohorts often incorporate detailed chemical exposure assessments via biomonitoring, alongside genotyping of mother-child pairs, yielding high-resolution data. Such approaches enable the identification of novel polymorphisms interacting with chemical exposures, providing promising leads on genetic determinants that might explain variability in fetal growth patterns and adverse birth outcomes like intrauterine growth restriction or preterm birth.
The biological mechanisms underpinning these gene-environment interactions frequently invoke pathways of oxidative stress, inflammation, and endocrine disruption. For instance, polymorphisms in genes coding for antioxidants or enzymes involved in reactive oxygen species metabolism can influence the extent of oxidative damage induced by chemical exposure. Similarly, genetic variation in cytokine signaling molecules mediating inflammatory responses may modulate placental function, subsequently impacting nutrient and oxygen delivery to the fetus. Furthermore, variations in hormone receptor genes could exacerbate disruptions caused by endocrine-disrupting chemicals, linking genetic predispositions to altered fetal hormonal milieus critical for normal growth trajectories.
Public health implications of these findings are profound. Understanding gene-environment interactions provides an opportunity for more targeted risk assessment and precision prevention strategies in prenatal care. Recognizing that certain genetic profiles may confer heightened vulnerability to specific chemical exposures empowers healthcare providers to personalize recommendations for exposure avoidance or mitigation. Additionally, these insights beckon regulatory agencies to evaluate environmental safety standards through a lens that accommodates genetic susceptibility, rather than relying solely on average population risk models.
Moreover, the arsenal of emerging technologies—including advanced genotyping platforms, exposomic profiling, and integrative multi-omics approaches—heralds the dawn of a more comprehensive dissection of the gene-environment nexus affecting prenatal health. Such innovations will likely fuel the discovery of previously unrecognized genetic variants and environmental contributors, fostering elucidation of causal pathways and biomarkers for early detection of at-risk pregnancies.
However, the review emphasizes the necessity for future research to address current limitations inherent in epidemiological studies of gene-environment interactions. These include small sample sizes, population stratification, and challenges in measuring low-level and mixed chemical exposures accurately. Harmonization of exposure assessment techniques, standardized definitions of birth outcomes, and inclusion of diverse populations globally are critical steps to bolster the robustness and generalizability of findings.
Ethical considerations also intersect with this emerging science. The prospect of genetic screening to identify heightened susceptibility raises questions about informed consent, data privacy, and potential stigmatization. Moreover, socio-economic disparities that influence both environmental exposures and access to genetic testing must be rigorously examined to avoid exacerbating health inequities. Integration of community engagement and transparent communication will be pivotal in responsibly translating scientific insights into clinical and public health interventions.
In closing, the narrative review by Kobayashi and colleagues propels forward the understanding of how gene-environment interactions shape birth outcomes amid prenatal chemical exposures. By expanding the genetic focus beyond well-characterized detoxification enzymes to include genes implicated in receptor signaling and transport, research is illuminating the complex networks orchestrating fetal development in chemically dynamic environments. While findings to date bear variability, they collectively signal the massive potential for personalized interventions aimed at safeguarding the most vulnerable stages of life.
As this scientific frontier advances, the synergy of genetics, toxicology, and epidemiology promises to unlock pivotal knowledge that may revolutionize prenatal healthcare. Targeted public health policies informed by gene-environment interplay could substantially reduce the global burden of adverse birth outcomes, ultimately fostering healthier generations. The imperative now is clear: sustained interdisciplinary efforts and innovative methodologies are indispensable to untangle the intricate genetic and environmental web influencing fetal growth, ensuring that future pregnancies unfold in an environment conducive to optimal development.
Subject of Research: Gene-environment interactions involving prenatal exposure to lifestyle-related and environmental chemicals and their effect on birth outcomes.
Article Title: Prenatal chemical exposures and fetal growth: a narrative review of gene-environment interactions (2025).
Article References:
Kobayashi, S., Sata, F., Saijo, Y. et al. Prenatal chemical exposures and fetal growth: a narrative review of gene-environment interactions (2025).
Pediatr Res (2026). https://doi.org/10.1038/s41390-026-04869-w
Image Credits: AI Generated
DOI: 02 March 2026
Tags: chemical exposures and birth outcomescytochrome P450 gene variants pregnancyenvironmental toxins impact on fetal developmentfetal growth and genetic predispositiongene-environment interactions in pregnancygenetic modulation of prenatal toxic riskgenetic polymorphisms and fetal growthglutathione S-transferase polymorphisms prenatalmaternal genetic susceptibility chemicalsnon-smoking related prenatal toxic exposuresprenatal chemical exposure effectsxenobiotic metabolism genes pregnancy
